Alliqua BioMedical, Inc. reported raising $2.77M in a private placement filing on March 13, 2017
Mar 15, 2017 - RelSci Data Update
Investments

Background Information:
Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Yardley, PA.
In The News:
Investor Expectations to Drive Momentum within Gorman-Rupp, Mistras Group, Inovalon, Johnson Controls International plc, Best Buy Co., and Alliqua BioMedical Discovering Underlying Factors of Influence
June 11, 2018  •  GlobeNewswire
Alliqua BioMedical, Inc. Announces Definitive Asset Purchase Agreement with Celularity, Inc.
January 5, 2018  •  GlobeNewswire
Jerome B. Zeldis is no longer serving in their board position at Alliqua BioMedical, Inc.
December 12, 2017  •  RelSci
Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Yardley, PA.